These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 9973448

  • 1. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.
    Tan LC, Gudgeon N, Annels NE, Hansasuta P, O'Callaghan CA, Rowland-Jones S, McMichael AJ, Rickinson AB, Callan MF.
    J Immunol; 1999 Feb 01; 162(3):1827-35. PubMed ID: 9973448
    [Abstract] [Full Text] [Related]

  • 2. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
    Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W.
    Virology; 1999 Nov 25; 264(2):289-97. PubMed ID: 10562493
    [Abstract] [Full Text] [Related]

  • 3. A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers.
    Yu HX, Srinivasan N, Ren EE, Chan SH.
    Tissue Antigens; 2005 Jun 25; 65(6):539-43. PubMed ID: 15896201
    [Abstract] [Full Text] [Related]

  • 4. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T, Ouyang Q, Flad T, Koetter I, Bühring HJ, Kalbacher H, Pawelec G, Müller CA.
    J Rheumatol; 2005 Feb 25; 32(2):239-51. PubMed ID: 15693083
    [Abstract] [Full Text] [Related]

  • 5. The human T cell immune response to Epstein-Barr virus.
    Landais E, Saulquin X, Houssaint E.
    Int J Dev Biol; 2005 Feb 25; 49(2-3):285-92. PubMed ID: 15906243
    [Abstract] [Full Text] [Related]

  • 6. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D.
    Eur J Immunol; 2005 Mar 25; 35(3):796-805. PubMed ID: 15724243
    [Abstract] [Full Text] [Related]

  • 7. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients.
    Macedo C, Donnenberg A, Popescu I, Reyes J, Abu-Elmagd K, Shapiro R, Zeevi A, Fung JJ, Storkus WJ, Metes D.
    Transpl Immunol; 2005 Jun 25; 14(2):109-16. PubMed ID: 15935301
    [Abstract] [Full Text] [Related]

  • 8. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF.
    Arthritis Res; 2000 Jun 25; 2(2):154-64. PubMed ID: 11062606
    [Abstract] [Full Text] [Related]

  • 9. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells.
    Vescovini R, Telera A, Fagnoni FF, Biasini C, Medici MC, Valcavi P, di Pede P, Lucchini G, Zanlari L, Passeri G, Zanni F, Chezzi C, Franceschi C, Sansoni P.
    Exp Gerontol; 2004 Aug 25; 39(8):1233-43. PubMed ID: 15288697
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.
    Vogl BA, Fagin U, Nerbas L, Schlenke P, Lamprecht P, Jabs WJ.
    J Med Virol; 2012 Jan 25; 84(1):119-31. PubMed ID: 22095540
    [Abstract] [Full Text] [Related]

  • 11. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N, Kimura H, Hara S, Hoshino Y, Kojima S, Morishima T, Tsurumi T, Kuzushima K.
    J Infect Dis; 2004 Sep 01; 190(5):985-8. PubMed ID: 15295706
    [Abstract] [Full Text] [Related]

  • 12. Contemporaneous fluctuations in T cell responses to persistent herpes virus infections.
    Crough T, Burrows JM, Fazou C, Walker S, Davenport MP, Khanna R.
    Eur J Immunol; 2005 Jan 01; 35(1):139-49. PubMed ID: 15597326
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B.
    J Immunol Methods; 2014 Jun 01; 408():101-13. PubMed ID: 24877879
    [Abstract] [Full Text] [Related]

  • 14. Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.
    Adhikary D, Behrends U, Moosmann A, Witter K, Bornkamm GW, Mautner J.
    J Exp Med; 2006 Apr 17; 203(4):995-1006. PubMed ID: 16549597
    [Abstract] [Full Text] [Related]

  • 15. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V, Höllsberg P.
    J Med Virol; 2004 Apr 17; 72(4):635-45. PubMed ID: 14981767
    [Abstract] [Full Text] [Related]

  • 16. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE.
    Berner BR, Tary-Lehmann M, Yonkers NL, Askari AD, Lehmann PV, Anthony DD.
    Cell Immunol; 2005 May 17; 235(1):29-38. PubMed ID: 16181618
    [Abstract] [Full Text] [Related]

  • 17. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y.
    Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466
    [Abstract] [Full Text] [Related]

  • 18. Identification of CD8+ T-cell epitopes specific for immediate-early transactivator Rta of Epstein-Barr virus.
    Yu H, Srinivasan N, Ren E, Chan S.
    Hum Immunol; 2005 May 20; 66(5):483-93. PubMed ID: 15935885
    [Abstract] [Full Text] [Related]

  • 19. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.
    White CA, Cross SM, Kurilla MG, Kerr BM, Schmidt C, Misko IS, Khanna R, Moss DJ.
    Virology; 1996 May 15; 219(2):489-92. PubMed ID: 8638417
    [Abstract] [Full Text] [Related]

  • 20. Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection.
    Woodberry T, Suscovich TJ, Henry LM, Davis JK, Frahm N, Walker BD, Scadden DT, Wang F, Brander C.
    J Infect Dis; 2005 Nov 01; 192(9):1513-24. PubMed ID: 16206065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.